Results 1 to 10 of about 26,355 (200)
Large Retrosternal Parathyroid Carcinoma with Primary Hyperparathyroidism [PDF]
Asian Journal of Surgery, 2007 Parathyroid carcinoma is an uncommon cause of parathyroid hormone (PTH)-dependent hypercalcaemia, accounting for less than 1% of all cases of hyperparathyroidism.
Geok Chin Tan +4 more
doaj +2 more sources
Discordant sestamibi uptake in synchronous parathyroid carcinoma and adenoma [PDF]
Endocrinology, Diabetes & Metabolism Case ReportsThe simultaneous occurrence of parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma is exceptionally rare. Herein, we present an uncommon case in which the right malignant parathyroid lesion was 99mTc-MIBI-negative and the ...
Qian Wang +4 more
doaj +2 more sources
Parathyroid carcinoma co-occurring with parathyroid adenoma and papillary thyroid carcinoma: a rare case report with comprehensive literature review [PDF]
Therapeutic Advances in Endocrinology and MetabolismParathyroid carcinoma is a rare endocrine malignancy with unclear etiology, and its clinical manifestations are often difficult to distinguish from parathyroid adenoma.
Junming Liu, Jingting Li, Yantao Fu
doaj +2 more sources
Synchronous intrathyroidal parathyroid carcinoma and thyroid carcinoma: case report and review of the literature [PDF]
BMC Endocrine Disorders, 2021 Background Parathyroid carcinoma is a rare endocrine malignancy, rarer when synchronous with a non medullary well differentiated thyroid carcinoma. Parathyroid carcinoma accounts of 0.005% of all malignant tumors and it is responsible for less than 1% of
Nadia De Falco +11 more
doaj +2 more sources
Synchronous parathyroid carcinoma and papillary thyroid carcinoma
Clinical Case Reports, 2022 The simultaneous occurrence of parathyroid carcinoma and nonmedullary thyroid carcinoma is unusual. We report the case of 60‐year‐old woman who was found to have concurrent parathyroid carcinoma with severe clinical manifestations of primary ...
Ibtissem Ben Nacef +8 more
doaj +1 more source
Clinical Case Reports, 2023 Key Clinical Message Rare cancer originating from parathyroid parenchymal cells. Preoperative diagnosis is often difficult. Presents with normal serum levels of calcium and parathyroid hormone. Treated by en bloc resection.
Alex Mremi +4 more
doaj +1 more source
Endocrine Connections, 2023 Nineteen cases of parathyroid carcinoma in patients with multiple endocrine neoplasia type 1 have been reported in the literature, of which 11 carry an inactivating germline mutation in the MEN1 gene.
Sara Lomelino Pinheiro +5 more
doaj +1 more source
Challenges in the Diagnosis of Parathyroid Cancer: Unraveling the Diagnostic Maze
Reports, 2023 Parathyroid carcinoma (PC) is a rare and aggressive cancer affecting the parathyroid glands, presenting diagnostic and therapeutic challenges due to its rarity and overlapping features with benign parathyroid disease.
Mihaela Stanciu +5 more
doaj +1 more source
Left parathyroid carcinoma with secondary hyperparathyroidism: a case report
BMC Endocrine Disorders, 2023 Background Parathyroid carcinoma is a rare disease with a frequency of 0.005% of all malignancies [1, 2]. Various aspects of its pathogenesis, diagnosis, and treatment remain poorly understood.
Ko Yokoyama +2 more
doaj +1 more source
BJS (British Journal of Surgery), EarlyView., 2020 This study investigated postoperative complications after surgery for medullary thyroid carcinoma (MTC) in Europe. Hypoparathyroidism, recurrent laryngeal nerve palsy and bleeding requiring reoperation occurred in 170 (26·2 per cent), 62 (13·7 per cent) and 17 (2·6 per cent) patients respectively.
D.‐J. van Beek +18 more
wiley +1 more source